π©πΎββοΈ CPC 52356 - Cystourethroscopy with Ureteroscopy and/or Pyeloscopy; with Lithotripsy Including Insertion of Indwelling Ureteral Stent
Full CPT Descriptor: Cystourethroscopy, with ureteroscopy and/or pyeloscopy; with lithotripsy (ureteral catheterization is included) including insertion of indwelling ureteral stent (e.g., Gibbon or double-J type)
π Procedure Overview
CPT 52356 describes the most comprehensive single-session endoscopic procedure for upper urinary tract stone management available in the ureteroscopy CPT code family. It captures three integrated therapeutic interventions performed during a single operative session through a single transurethral endoscopic access:
- Ureteroscopy and/or pyeloscopy β passage of a rigid or flexible ureteroscope transurethrally through the bladder into the ureter and/or renal pelvis to access a calculus
- Lithotripsy β in-situ fragmentation of the calculus using an energy-based intracorporeal device (most commonly Holmium:YAG laser, but also ultrasonic, electrohydraulic, or pneumatic/ballistic; in contemporary practice, the Holmium:YAG laser is the overwhelming standard of care for ureteroscopic lithotripsy, with emerging use of Thulium fiber laser)
- Insertion of an indwelling ureteral stent β placement of a self-retaining internal ureteral stent (most commonly a double-J or pigtail stent, also referred to as a Gibbon stent per the CPT descriptor) at the conclusion of the procedure to maintain ureteral drainage, prevent obstruction from edema or residual fragments, and facilitate fragment passage
52356 is distinct from 52353 (ureteroscopy with lithotripsy without stent placement) in that stent placement is explicitly included in and required by the code descriptor. This is not merely an add-on β it is a defining component. When lithotripsy is performed and a stent is placed in the same session, 52356 is the correct and complete code. 52353 and 52332 (stent placement) should not be reported together as a substitute for 52356 when both lithotripsy and stent are performed simultaneously.
Because ureteroscopy inherently requires ureteral access, ureteral catheterization is explicitly bundled into 52356 and is not separately reportable.
52356 carries the highest wRVU of all standard ureteroscopy codes (52351-52356), reflecting the increased complexity, procedural time, technical skill, and equipment requirements of combining laser lithotripsy with stent placement compared to other ureteroscopic interventions.
βοΈ Procedural Mechanics
The procedure typically proceeds as follows:
Pre-Procedure Setup
- Patient is placed in dorsal lithotomy position under general, spinal, or MAC anesthesia.
- A Foley catheter may or may not be placed initially; the urethral access for the ureteroscope negates the need for a separate Foley in most cases.
- Fluoroscopy (C-arm) is positioned for intraoperative imaging.
Cystoscopy and Access
- Cystoscopy is performed β the bladder is inspected (bundled; 52000 not separately reportable).
- The ureteral orifice of the affected side is identified.
- A safety guide wire (hydrophilic or stiff, e.g., Sensor wire, Amplatz Super Stiff) is passed under fluoroscopic guidance through the ureteral orifice and advanced to the renal pelvis.
- A working guide wire may be placed alongside the safety wire.
- Ureteral access sheath (UAS) placement β at the surgeonβs discretion, a ureteral access sheath (e.g., 9.5/11.5 Fr Cook UAS) may be deployed to facilitate multiple scope passes and improve irrigation flow. The UAS is considered bundled and not separately reportable.
Ureteroscopy and Stone Visualization
- A flexible or rigid ureteroscope is advanced over or alongside the guide wire to the level of the calculus β which may be in the ureter (proximal, mid, distal) or within the renal pelvis/calyces.
- The stone is identified and assessed for size, location, composition appearance, and degree of impaction.
Lithotripsy
- A laser fiber (most commonly 200-365 Β΅m Holmium:YAG; or Thulium fiber laser [TFL] at select centers) or other energy source is passed through the working channel of the ureteroscope to the level of the stone.
- Laser lithotripsy is performed:
- Fragmentation technique: Stone is broken into multiple extractable pieces, followed by basketing of larger fragments
- Dusting technique: Stone is pulverized into fine powder (<0.5 mm particles) intended for spontaneous passage; associated with reduced basketing but may leave residual dust
- Pop-dusting / combination: Hybrid technique combining fragmentation and dusting
- Stone fragments may be extracted using a Nitinol basket (tipless, zero-tip, or flat wire), forceps, or suctioning through the UAS β these extraction maneuvers are bundled into 52356.
- Fluoroscopic spot films confirm stone clearance or document residual fragments.
Stent Placement
- At the conclusion of lithotripsy, an indwelling ureteral stent is placed:
- The stent (typically a 4.7-7 Fr double-J or double-pigtail stent, 22-30 cm in length) is loaded over the existing guide wire.
- Under fluoroscopic and/or endoscopic visualization, the stent is advanced so the proximal curl sits in the renal pelvis and the distal curl sits in the bladder.
- Correct positioning is confirmed fluoroscopically.
- Stent string (retrieval suture) may or may not be left externalized through the urethra depending on the planned duration of stenting and patient/surgeon preference.
- The ureteroscope and guide wire are removed; Foley catheter may be placed post-procedure if needed.
Common Indications for Stent Placement After Ureteroscopic Lithotripsy:
- Significant ureteral edema or mucosal trauma during stone manipulation
- Residual stone fragments anticipated (incomplete clearance β βdustingβ technique)
- Ureteral stricture or narrowing encountered during the procedure
- Large stone burden (β₯2 cm) requiring staged procedure
- Solitary kidney (risk mitigation)
- Infection/urosepsis (obstruction relief)
- Anticipated prolonged healing (e.g., impacted stone)
- Anatomic abnormality (UPJ obstruction, ureteral kink)
- Pre-stenting for passive dilation before planned repeat ureteroscopy
π° Reimbursement & RVU Data
| Component | Value (Approximate - Verify Current Year CMS MPFS)1 |
|---|---|
| Work RVU (wRVU) | 9.78 |
| Non-Facility Total RVU | ~17.42 |
| Facility Total RVU | ~12.85 |
| Global Period | 000 (Zero-day global) |
| Assistant Surgeon Payable | β No (Medicare Indicator: 0) |
| Bilateral Surgery Indicator | 3 - Cannot be bilateral (endoscopic; inherently unilateral per scope pass/stent) |
| Co-Surgeon | β Not applicable |
| Team Surgery | β Not applicable |
β οΈ wRVU Hierarchy Within the Ureteroscopy Family:
Code Procedure wRVU (Approx.) 52351 Diagnostic ureteroscopy 3.00 52352 Ureteroscopy + stone removal/manipulation 7.26 52353 Ureteroscopy + lithotripsy (no stent) 8.45 52354 Ureteroscopy + biopsy/fulguration 8.10 52355 Ureteroscopy + tumor resection 9.50 52356 Ureteroscopy + lithotripsy + stent 9.78 52356 carries the highest wRVU in the ureteroscopy family, reflecting the combined technical work of lithotripsy AND stent placement in a single session.
β οΈ Annual Update Reminder: wRVU and total RVU values are subject to annual CMS MPFS rulemaking. Always verify against the current yearβs CMS Physician Fee Schedule Look-Up Tool.1
β Includes (Bundled β Do Not Bill Separately)
The following services are inherently included within 52356 and are not separately reportable in the same operative session for the same ureter:
- Ureteral catheterization β explicitly stated in the code descriptor
- Cystoscopy / cystourethroscopy (52000) β transurethral access to the ureteral orifice is integral to the approach
- Diagnostic ureteroscopy component (52351) β visualization and assessment of the ureter/renal pelvis is inherent when a therapeutic procedure is performed
- Laser fiber placement and energy delivery β the act of passing the laser fiber through the working channel and activating the laser is bundled; there is no separate CPT for laser use during ureteroscopy
- Stone fragmentation β whether the surgeon uses fragmentation, dusting, or pop-dusting technique, the lithotripsy is a single bundled service
- Stone fragment extraction/basketing β basket retrieval of fragments following lithotripsy is included; the stone removal component of 52352 is bundled when lithotripsy also occurs
- Ureteral access sheath (UAS) placement β placement and use of the UAS is bundled; there is no separate CPT for UAS deployment
- Fluoroscopic guidance β intraoperative fluoroscopy used during standard ureteroscopy navigation and stent placement is bundled under most payer policies
- Ureteral stent insertion (52332) β critically, stent placement is explicitly named in the descriptor of 52356 and is thus entirely bundled; 52332 must never be separately reported when 52356 is billed for the same ureter in the same session
- Irrigation and ureteral dilation as needed to pass the scope
- Guide wire placement and manipulation
- Intraoperative spot fluoroscopic films for stent position confirmation
- Retrograde pyelogram if performed during the ureteroscopy session as part of access β payer-dependent; many MACs bundle 74420 (retrograde ureterography)
π« Excludes / Cannot Bill Together (NCCI Edits, Bundling & Mutual Exclusivity)
Critical Bundling β Never Report Together for Same Ureter/Same Session
| Bundled Code | Description | Why Bundled |
|---|---|---|
| 52332 | Cystoscopy with insertion of indwelling ureteral stent | Stent placement is explicitly named in 52356 descriptor β reporting 52332 separately with 52356 for the same ureter is a significant NCCI violation; stent is 100% bundled |
| 52353 | Ureteroscopy with lithotripsy (no stent) | Mutually exclusive β 52356 is the correct code when both lithotripsy AND stent are performed; do not report 52353 + 52332 as a substitute for 52356 |
| 52351 | Diagnostic ureteroscopy | Bundled β diagnostic component is integral when therapeutic procedure is performed |
| 52000 | Cystourethroscopy | Bundled β bladder access is inherent to ureteroscopic approach |
| 52005 | Cystoscopy with ureteral catheterization | Bundled β ureteral catheterization explicitly included in descriptor |
| 52352 | Ureteroscopy with stone removal/manipulation | Bundled β stone manipulation/extraction is part of the lithotripsy workflow; when lithotripsy is performed, 52353 or 52356 (not 52352) is the appropriate code |
| 76000 | Fluoroscopy, up to 1 hour | Typically bundled; not separately reportable during standard ureteroscopy |
| 74420 | Retrograde ureterography | Typically bundled by most MACs when performed as part of ureteroscopic access |
β οΈ Most Common Billing Error for 52356: Reporting 52353 + 52332 instead of 52356 when both lithotripsy and stent are performed in the same session. This is both incorrect and, in many cases, results in higher reimbursement than 52356 alone, making it an active target for payer audits and NCCI enforcement. The CPT instruction is explicit: when lithotripsy is performed AND a stent is inserted in the same ureteroscopic session, the correct and complete code is 52356 β a single code β not a combination of 52353 + 52332.2
Separately Reportable β Contralateral Ureter (Different Anatomic Structure)
| Separately Reportable Code | Scenario | Modifier Required |
|---|---|---|
| 52356--LT + 52356--RT | Bilateral ureteroscopy with lithotripsy AND stent in BOTH ureters in same session | -51 on the lower-valued code; both units reportable for separate ureters |
| 52356--LT + 52353--RT | Left ureter: lithotripsy + stent (52356); Right ureter: lithotripsy without stent (52353) | -51 on lower-valued code; -LT/-RT laterality modifiers required |
| 52356--RT + 52352--LT | Right ureter: lithotripsy + stent (52356); Left ureter: stone manipulation only (52352) | -51 on lower-valued code |
Bilateral Ureteroscopy Coding Logic: When procedures are performed in both ureters during the same operative session, each ureter is coded separately with appropriate laterality modifiers. The bilateral surgery indicator of 3 means 52356 itself cannot be reported as a βbilateralβ service on a single line β it must be reported twice (once per ureter) with -LT and -RT respectively, with -51 on the lesser-valued code. Some payers bundle the second unit regardless of modifier β verify before submitting.
Separately Reportable β Different Anatomic Site (Same Session)
| Separately Reportable Code | Scenario | Modifier |
|---|---|---|
| 52204 | Bladder biopsy (separate bladder lesion biopsied during same cystoscopy) | -59/-XS β distinct anatomic site (bladder vs. ureter) |
| 52214 | Bladder fulguration (separate bladder lesion treated during same session) | -59/-XS β distinct site |
| 52000 | Cystoscopy for separate bladder indication | Rarely separately reportable; payer-specific; requires strong documentation |
| 50590 | ESWL (if performed on a different stone/different anatomic target on a separate date) | Separate date of service; no modifier conflict |
Separately Reportable β Percutaneous Nephrostomy / Access Codes (Different Approach)
| Code | Description | Notes |
|---|---|---|
| 50080 | PCNL up to 2 cm | Different approach (percutaneous); separately reportable if performed on different date or for distinctly different stone/access |
| 50081 | PCNL greater than 2 cm | Same as above |
| 50392 | Introduction of ureteral catheter or stent, percutaneous approach | Different approach β percutaneous vs. endoscopic; not a conflict with 52356 |
π³ Code Tree - Ureteroscopy / Pyeloscopy Complete Family
Cystourethroscopy with Ureteroscopy and/or Pyeloscopy
(Ureteral catheterization included in all codes below)
β
βββ 52351 - Diagnostic ureteroscopy and/or pyeloscopy
β (Visualization only β no therapeutic intervention)
β wRVU: ~3.00
β
βββ 52352 - With removal or manipulation of calculus
β (Basket extraction, forceps, or stone manipulation/repositioning)
β (Does NOT involve lithotripsy energy device)
β wRVU: ~7.26
β
βββ 52353 - With lithotripsy
β (Holmium laser, TFL, ultrasonic, EHL, or pneumatic fragmentation)
β (NO stent placement β if stent placed, use 52356 instead)
β wRVU: ~8.45
β
βββ 52354 - With biopsy and/or fulguration of lesion
β (Upper tract urothelial lesion β tissue sampling and/or ablation)
β wRVU: ~8.10
β
βββ 52355 - With resection of ureteral or pelvic tumor
β (More extensive endoscopic tumor resection than biopsy/fulguration)
β wRVU: ~9.50
β
βββ 52356 β THIS CODE - With lithotripsy INCLUDING insertion of indwelling ureteral stent
(Lithotripsy [laser/energy] + stent placement in same session)
(Highest wRVU in the ureteroscopy family)
(Stent is part of the code β NEVER separately bill 52332)
wRVU: ~9.78
Stone-Specific Ureteroscopy Decision Tree:
Ureteroscopy for Calculus β Which Code?
β
βββ Scope passed; stone VISUALIZED; no therapeutic intervention performed
β βββ 52351 (diagnostic ureteroscopy β stone noted but not treated)
β
βββ Stone BASKETED or MANIPULATED; no energy device used
β βββ 5235 (removal or manipulation of calculus)
β
βββ Lithotripsy (energy) performed; NO stent placed at conclusion
β βββ 52353 (ureteroscopy with lithotripsy; no stent)
β
βββ Lithotripsy (energy) performed; STENT PLACED at conclusion
βββ 52356 β (ureteroscopy with lithotripsy + stent)
β
βββ Do NOT separately bill 52332 for the stent
βββ Do NOT report 52353 + 52332 instead of 52356
βββ 52356 = one code, all three services bundled
Related Stone Surgery Codes Outside the Ureteroscopy Family:
Upper Urinary Tract Stone Surgery β Broader Context
β
βββ ENDOSCOPIC (Ureteroscopic) - Retrograde approach
β βββ 52352 - URS stone removal/manipulation (no energy)
β βββ 52353 - URS with lithotripsy (no stent)
β βββ 52356 β THIS CODE - URS with lithotripsy + stent
β
βββ EXTRACORPOREAL
β βββ 50590 - Extracorporeal shock wave lithotripsy (ESWL)
β (Non-invasive; external shock waves; no scope)
β
βββ PERCUTANEOUS (Antegrade approach)
β βββ 50080 - PCNL, up to 2 cm stone
β βββ 50081 - PCNL, greater than 2 cm stone
β
βββ OPEN / LAPAROSCOPIC (Rare; reserved for complex cases)
βββ 50060 - Nephrolithotomy; removal of calculus
βββ 50065 - Nephrolithotomy; secondary surgical procedure
βββ 50130 - Pyelolithotomy; removal of calculus
βββ 50945 - Laparoscopic ureterolithotomy
π₯ ICD-10-CM Diagnosis Codes Commonly Paired with 52356
Primary Stone Disease Diagnoses
| ICD-10-CM Code | Description | HCC v24 | HCC v28 |
|---|---|---|---|
| N20.0 | Calculus of kidney | β No | β |
| N20.1 | Calculus of ureter | β No | β |
| N20.2 | Calculus of kidney with calculus of ureter | β No | β |
| N21.0 | Calculus in bladder | β No | β |
| N21.8 | Other lower urinary tract calculus | β No | β |
Laterality Note: ICD-10-CM stone codes (N20.0, N20.1, N20.2) do not include laterality at the code level β there is no βright ureter calculusβ vs. βleft ureter calculusβ distinction in ICD-10-CM. Laterality for 52356 is communicated through CPT modifiers (-LT, -RT) appended to the procedure code, not through ICD-10-CM diagnosis code selection.
HCC Note: Urinary calculus codes are not mapped to any HCC category under either CMS-HCC v24 or v28. Urolithiasis is an episodic, generally treatable condition that does not carry risk-adjustment value in the HCC model. However, comorbid conditions documented at the same encounter β particularly CKD, diabetes, sepsis, or obstructive nephropathy β may carry significant HCC weight and must be captured when documented and clinically relevant.
Obstructive & Hydronephrosis Codes
| ICD-10-CM Code | Description | HCC v24 | HCC v28 |
|---|---|---|---|
| N13.0 | Hydronephrosis with ureteropelvic junction obstruction | β No | β |
| N13.1 | Hydronephrosis with ureteral stricture, NEC | β No | β |
| N13.2 | Hydronephrosis with renal and ureteral calculous obstruction | β No | β |
| N13.30 | Unspecified hydronephrosis | β No | β |
| N13.39 | Other hydronephrosis | β No | β |
| N13.5 | Crossing vessel and stricture of ureter without hydronephrosis | β No | β |
| N13.6 | Pyonephrosis | β No | β |
N13.2 Clinical Significance: This code β hydronephrosis with renal and ureteral calculous obstruction β is one of the most important secondary diagnoses for 52356 cases. An obstructing ureteral stone with upstream hydronephrosis represents a medical urgency (or emergency if infected) that justifies hospitalization and immediate intervention. Accurate coding of N13.2 alongside the stone code captures the clinical severity and may impact DRG assignment when the case is inpatient.
N13.6 β Pyonephrosis: Represents an infected, obstructed collecting system β a urologic emergency. When 52356 is performed in the setting of pyonephrosis (obstructing stone + infection + purulent urine), N13.6 should be coded as it reflects the most severe manifestation of the clinical scenario and carries implications for DRG assignment and quality reporting.
Infectious Complications
| ICD-10-CM Code | Description | HCC v24 | HCC v28 |
|---|---|---|---|
| N10 | Acute pyelonephritis | β No | β |
| N11.9 | Chronic tubulo-interstitial nephritis, unspecified | β No | β |
| N39.0 | Urinary tract infection, site not specified | β No | β |
| N30.00 | Acute cystitis without hematuria | β No | β |
| A41.9 | Sepsis, unspecified organism | HCC 2 | HCC 2 |
| A41.51 | Sepsis due to Escherichia coli | HCC 2 | HCC 2 |
| A41.59 | Other Gram-negative sepsis | HCC 2 | HCC 2 |
| A41.01 | Sepsis due to Methicillin-susceptible Staphylococcus aureus | HCC 2 | HCC 2 |
| B37.49 | Other urogenital candidiasis | β No | β |
Urosepsis Coding Guidance: βUrosepsisβ is a clinically used but ICD-10-CM-undefined term. Per AHA Coding Clinic guidance and ICD-10-CM Official Guidelines, the term βurosepsisβ by itself does not default to a sepsis code in ICD-10-CM. When a physician documents βurosepsis,β a physician query is required to clarify whether the patient meets the clinical criteria for sepsis (A41.xx) or whether the documentation indicates only a urinary source of infection without systemic septic response (N39.0 or N10 for the localized infection). Sepsis (A41.xx) is an MCC in the MS-DRG system and has HCC 2 mapping β accurate coding of this distinction has significant clinical, financial, and quality implications.3
High-Value Comorbidity Diagnoses (HCC-Relevant)
| ICD-10-CM Code | Description | HCC v24 | HCC v28 |
|---|---|---|---|
| N18.1 | CKD, stage 1 | β No | β |
| N18.2 | CKD, stage 2 | β No | β |
| N18.30 | CKD, stage 3, unspecified | HCC 137 | HCC 329 |
| N18.31 | CKD, stage 3a | HCC 137 | HCC 329 |
| N18.32 | CKD, stage 3b | HCC 137 | HCC 329 |
| N18.4 | CKD, stage 4 | HCC 137 | HCC 329 |
| N18.5 | CKD, stage 5 | HCC 136 | HCC 328 |
| N18.6 | End stage renal disease | HCC 136 | HCC 328 |
| E11.65 | Type 2 diabetes mellitus with hyperglycemia | HCC 19 | HCC 37 |
| E11.649 | Type 2 DM with hypoglycemia, without coma | HCC 19 | HCC 37 |
| E11.40 | Type 2 DM with diabetic neuropathy, unspecified | HCC 18 | HCC 35 |
| E11.65 | Type 2 DM with hyperglycemia | HCC 19 | HCC 37 |
| I50.9 | Heart failure, unspecified | HCC 85 | HCC 221 |
| E66.01 | Morbid (severe) obesity | HCC 22 | HCC 48 |
| D57.1 | Sickle-cell disease without crisis | HCC 46 | HCC 116 |
| D57.00 | Sickle-cell disease with crisis, unspecified | HCC 46 | HCC 116 |
CKD & Stone Disease Intersection: Patients with chronic kidney disease are particularly high-risk for stone disease complications β obstructing stones in CKD patients can precipitate acute-on-chronic kidney injury and AKI requiring urgent intervention. CKD stage must be documented and coded at every qualifying encounter. CKD staging codes carry HCC weight and significantly impact DRG tier for inpatient cases. Additionally, renal tubular acidosis and other metabolic conditions predisposing to stone formation (cystinuria, hyperoxaluria, hyperparathyroidism) should be coded when documented as they contribute to complete clinical picture.
Sickle Cell Disease and Urolithiasis: Patients with sickle cell disease are at increased risk for calcium-containing calculi and renal papillary necrosis mimicking stone disease. D57.xx codes carry HCC weight and must be coded when documented and clinically relevant to the encounter.
Metabolic Stone Disease & Predisposing Conditions
| ICD-10-CM Code | Description | HCC | |
|---|---|---|---|
| E83.59 | Other disorders of calcium metabolism (hypercalciuria) | β No | |
| E79.0 | Hyperuricemia without signs of inflammatory arthritis | β No | |
| E74.818 | Other disorders of fructose metabolism | β No | |
| N25.81 | Secondary hyperparathyroidism of renal origin | β No | |
| E21.0 | Primary hyperparathyroidism | β No | |
| E72.11 | Homocystinuria | β No | |
| E72.01 | Cystinuria | β No | |
| N04.9 | Nephrotic syndrome, unspecified | β No | |
| Q61.3 | Polycystic kidney disease, unspecified | HCC 139 (v24) | HCC 331 (v28) |
| N28.89 | Other specified disorders of kidney and ureter (e.g., medullary sponge kidney) | β No | |
| K59.00 | Constipation, unspecified (Crohnβs/IBD-related oxalate stones) | β No | |
| K50.90 | Crohnβs disease, unspecified, without complications | β No |
Hematuria Codes
| ICD-10-CM Code | Description | HCC |
|---|---|---|
| R31.0 | Gross hematuria | β No |
| R31.1 | Benign essential microscopic hematuria | β No |
| R31.21 | Asymptomatic microscopic hematuria | β No |
| R31.29 | Other microscopic hematuria | β No |
| R31.9 | Hematuria, unspecified | β No |
Post-Procedure / Complication Codes
| ICD-10-CM Code | Description | HCC |
|---|---|---|
| T83.192A | Other mechanical complication of indwelling ureteral stent, initial encounter | β No |
| T83.592A | Infection due to indwelling ureteral stent, initial encounter | β No |
| T83.598A | Infection due to other prosthetic device in urinary system, initial encounter | β No |
| N99.89 | Other postprocedural complications of genitourinary system | β No |
| S37.12XA | Contusion of ureter, initial encounter | β No |
| S37.19XA | Other injury of ureter, initial encounter | β No |
| R31.0 | Gross hematuria (post-procedure) | β No |
| N13.6 | Pyonephrosis (infected obstructed system post-procedure) | β No |
| N99.0 | Postprocedural renal failure | HCC 136/137 |
Stent-Related Symptom Codes (Post-Procedure Stent Management)
| ICD-10-CM Code | Description | HCC |
|---|---|---|
| N39.41 | Urge incontinence (common stent symptom) | β No |
| R35.0 | Frequency of micturition | β No |
| R30.0 | Dysuria | β No |
| R39.89 | Other specified symptoms and signs involving the genitourinary system (stent discomfort/pain) | β No |
| T83.192A | Mechanical complication of indwelling ureteral stent (e.g., migration, encrustation) | β No |
Stent-Related Symptom Coding: Patients with indwelling ureteral stents frequently experience storage and voiding lower urinary tract symptoms (urgency, frequency, dysuria, hematuria, flank discomfort). These are expected physiologic responses to stent presence, not necessarily complications. When a patient presents specifically for stent-related symptoms, code the stent complication/symptom code along with a status code for the presence of the stent if documented. Z96.0 (presence of urogenital implants) or a more specific stent presence code may be used for status documentation.
π¨ MS-DRG Assignment
Inpatient Coding Note: CPT codes drive physician/professional fee billing and outpatient facility (OPPS/APC) claims. For inpatient hospital (UB-04) billing, ICD-10-PCS procedure codes β not CPT β drive MS-DRG assignment through the GROUPER. 52356 falls under MDC 11 (Diseases & Disorders of the Kidney & Urinary Tract) for most stone/urolithiasis presentations.
Relevant MS-DRGs β MDC 11 (Urinary Stone β Standard Presentation)
| MS-DRG | Description | Approx. Relative Weight4 |
|---|---|---|
| 693 | Urinary Stones w/ Other O.R. Procedure w/ MCC | ~1.80 |
| 694 | Urinary Stones w/ Other O.R. Procedure w/ CC | ~1.10 |
| 695 | Urinary Stones w/ Other O.R. Procedure w/o CC/MCC | ~0.85 |
| 696 | Urinary Stones w/o O.R. Procedure w/ MCC | ~1.20 |
| 697 | Urinary Stones w/o O.R. Procedure w/ CC | ~0.74 |
| 698 | Urinary Stones w/o O.R. Procedure w/o CC/MCC | ~0.55 |
DRGs 693-695 are triggered when the principal diagnosis is urinary calculus (N20.x, N13.2, etc.) AND a qualifying ICD-10-PCS OR procedure is performed (ureteroscopy with lithotripsy and stent = qualifies as OR procedure). DRGs 696-698 apply when no qualifying OR procedure is performed (medical management only).
CC/MCC Impact: The difference between DRG 693 (w/ MCC, ~1.80 relative weight) and DRG 695 (w/o CC/MCC, ~0.85 relative weight) represents a >2x difference in facility reimbursement for the same principal diagnosis. CDI queries targeting sepsis, CKD stage, AKI, and other comorbidities can significantly affect DRG tier.
Sepsis as Principal Diagnosis (Shifts to MDC 18)
When an obstructing stone results in sepsis and the physician documents sepsis as the principal diagnosis (the condition chiefly responsible for the admission after study), the case shifts from MDC 11 to MDC 18 (Infectious & Parasitic Diseases) with dramatically different β and typically higher-weighted β DRG assignments:
| MS-DRG | Description | Approx. Relative Weight4 |
|---|---|---|
| 871 | Septicemia or Severe Sepsis w/ MV >96 hours | ~6.50 |
| 872 | Septicemia or Severe Sepsis w/o MV >96 hours w/ MCC | ~1.90 |
| 873 | Septicemia or Severe Sepsis w/o MV >96 hours w/o MCC | ~1.10 |
Principal Diagnosis Sequencing β Stone + Sepsis: This is one of the most consequential and frequently debated sequencing decisions in urologic inpatient coding. The condition that after study is determined to have been chiefly responsible for the admission is the principal diagnosis. If the patient was admitted primarily because of sepsis (systemic inflammatory response, hemodynamic instability, bacteremia) caused by an obstructing stone, sepsis (A41.xx) is the principal diagnosis and the stone (N20.1, N13.2) is secondary. This shifts the case to MDC 18 and can result in substantially higher DRG-based reimbursement. Conversely, if the stone/obstruction was the admitting reason and sepsis developed during the hospitalization, the stone may remain principal. Always review the admission H&P, attendingβs documentation of the reason for admission, and the final discharge summary. When ambiguous, a CDI or physician query is appropriate.3
ICD-10-PCS Equivalents (Inpatient Facility Billing)
Root Operation: Fragmentation (F) βBreaking solid matter in a body part into piecesβ β does NOT remove the fragments; just breaks them
| ICD-10-PCS Code | Description |
|---|---|
| 0TF67ZZ | Fragmentation in right ureter, via natural or artificial opening endoscopic |
| 0TF77ZZ | Fragmentation in left ureter, via natural or artificial opening endoscopic |
| 0TF37ZZ | Fragmentation in right kidney pelvis, via natural or artificial opening endoscopic |
| 0TF47ZZ | Fragmentation in left kidney pelvis, via natural or artificial opening endoscopic |
| 0TF87ZZ | Fragmentation in bilateral ureters, via natural or artificial opening endoscopic |
Root Operation β Fragmentation vs. Extirpation: This is a critical ICD-10-PCS coding distinction:
- Fragmentation (F): Used when the stone is broken into pieces using energy (laser, ultrasonic, EHL) β the intent is to fragment, not extract. Even if some fragments are subsequently basketed, the primary root operation for lithotripsy is Fragmentation. This is the correct root operation for 52356-equivalent procedures.
- Extirpation (C): Used when solid matter is removed from a body part β appropriate for stone basket extraction without energy (the 52352 equivalent). When lithotripsy (energy fragmentation) precedes extraction, Fragmentation remains the primary root operation.
- If both fragmentation AND extraction occur in the same procedure (stone broken then basketed), Fragmentation is coded as the primary root operation; the extraction component is integral and not separately coded.3
Ureteral Stent Placement β ICD-10-PCS
The root operation for ureteral stent placement depends on the intent and effect of the stent:
| Root Operation | PCS Code | Description | When Used |
|---|---|---|---|
| Dilation (7) β with intraluminal device | 0T778DZ | Dilation of right ureter with intraluminal device, via natural or artificial opening endoscopic | When stent is placed to dilate/maintain a strictured or narrowed ureter β the stentβs primary purpose is dilation |
| Bypass (1) | 0T170DZ / 0T177DZ | Bypass, right ureter, open/endoscopic | When stent reroutes urine flow around an obstruction β though controversial for simple post-ureteroscopy stenting |
| Drainage (9) with drainage device | 0T997DZ | Drainage of right ureter with drainage device, endoscopic | When stent is placed primarily for drainage (e.g., post-obstruction decompression) |
β οΈ ICD-10-PCS Stent Root Operation β Ongoing Controversy: The correct root operation for routine post-ureteroscopy double-J stent placement has been the subject of multiple AHA Coding Clinic queries and continues to evolve. The most commonly applied guidance has defaulted to Dilation (7) with an intraluminal device character (D) for stents placed to maintain ureteral patency after ureteroscopy. However, individual facility policy, recent Coding Clinic updates, and payer-specific guidance should always take precedence over general guidance here. When uncertain, query your facilityβs coding compliance team or reference the most recent applicable AHA Coding Clinic issue.3
Combined ICD-10-PCS Coding for 52356 Equivalent (Right Ureter Example):
Principal Procedure: 0TF67ZZ β Fragmentation, right ureter, endoscopic
Secondary Procedure: 0T778DZ β Dilation, right ureter with intraluminal device, endoscopic
(stent placement β verify root operation per facility policy/Coding Clinic)
π·οΈ Modifiers Applicable to 52356
| Modifier | Description | Use Case |
|---|---|---|
| -LT | Left side | Stone/procedure in left ureter or left renal pelvis/calyces |
| -RT | Right side | Stone/procedure in right ureter or right renal pelvis/calyces |
| -22 | Increased procedural services | Unusually complex ureteroscopy β impacted stone requiring prolonged laser time, severely tortuous ureter, complete ureteral obstruction requiring extensive dilation, multiple stones requiring prolonged procedure, horseshoe kidney anatomy, prior ureteral reconstruction; operative note must document specific circumstances of increased work, time, and complexity; written attestation strengthens the claim |
| -51 | Multiple procedures | When 52356 is reported for one ureter alongside a separately reportable procedure for the contralateral ureter or a different anatomic site (e.g., bilateral ureteroscopy, concurrent bladder procedure); applied to the lower-valued code |
| -52 | Reduced services | Procedure initiated but not fully completed β e.g., laser lithotripsy begun but stone not fully fragmented; stent placed but lithotripsy incomplete due to equipment failure or clinical decision to stage; document the specific reason for reduction |
| -53 | Discontinued procedure | Procedure initiated and terminated before therapeutic completion due to patient safety (e.g., anesthetic complication, hemodynamic instability discovered during ureteroscopy) |
| -58 | Staged or related procedure | If 52356 is being performed as a planned staged second procedure following an initial ureteroscopy (e.g., stent placed at first session for passive dilation; definitive lithotripsy + stent exchange at second session β within the 000-day global of the first procedure, though the 000-day global means this is rarely clinically relevant; more applicable if within the global period of a related major procedure) |
| -59 | Distinct procedural service | Used to unbundle a separately reportable service from 52356 performed at a genuinely distinct anatomic site (e.g., bilateral ureteroscopy where NCCI bundling would otherwise apply; bladder procedure billed separately); payer-dependent; -XS preferred by some MACs |
| -76 | Repeat procedure by same physician | If 52356 must be repeated on the same day by the same surgeon (unusual; clinical documentation of necessity required β e.g., stent malposition requiring immediate replacement) |
| -77 | Repeat procedure by different physician | If 52356 is repeated same day by a different physician of the same group |
| -78 | Unplanned return to OR, related procedure | If patient returns to OR during the global period of a related major procedure (e.g., 52356 performed during the global period of a prior nephrolithotomy or PCNL for a related residual stone or complication) |
| -79 | Unrelated procedure during global period | 52356 performed during the 90-day global of an unrelated major surgery |
| -XS | Separate structure | CMS preferred alternative to -59 for distinct structural/anatomic sites; preferred by many MACs for bilateral ureteroscopy claims or when bladder procedures are billed alongside upper tract procedures |
Laterality Is Mandatory for 52356: Because the ureter has distinct left and right anatomy and stent placement is unilateral, always append -LT or -RT to 52356. Submission without laterality modifiers is a common denial trigger and may result in medical review requests. If the stone is truly at the ureteropelvic junction or in the renal pelvis of a horseshoe kidney, document the laterality and anatomy explicitly in the operative note and apply the appropriate laterality modifier.
Modifier -22 for Complex Ureteroscopy: 52356 with -22 is supportable in several well-documented clinical scenarios: impacted proximal ureteral stones (prolonged dilation and laser time), staghorn calculi treated endoscopically in staged fashion (large stone burden), severely tortuous ureters requiring multiple attempts at access and unusual instrument selection, prior ureteral surgery with altered anatomy or strictures, horseshoe or pelvic kidney anatomy requiring non-standard scope orientation, and ureteroenteric anastomosis stricture with stone (e.g., in ileal conduit patients). In all cases, the operative note must explicitly and specifically describe the unusual technical challenges β generic βdifficult caseβ language is insufficient for -22 support.
π Coding Examples
Example 1 - Standard Holmium Laser Lithotripsy with Double-J Stent, Outpatient
A 45-year-old male presents with left flank pain. CT scan confirms a 1.2 cm left proximal ureteral stone with mild hydronephrosis. The urologist performs cystourethroscopy, advances a flexible ureteroscope into the left ureter, identifies the impacted proximal stone, and performs Holmium:YAG laser lithotripsy using a dusting technique with a 200 Β΅m laser fiber. Fluoroscopy confirms adequate fragmentation. A 6 Fr Γ 26 cm double-J ureteral stent is placed over the guide wire with proximal coil in the left renal pelvis and distal coil in the bladder. Fluoroscopy confirms appropriate stent position. Estimated procedure time 42 minutes.
CPT: 52356--LT ICD-10-CM: N20.1 (calculus of ureter)
β Lithotripsy performed + stent placed = 52356. Do NOT report 52353--LT + 52332--LT. The stent is bundled into 52356 by descriptor definition.
Example 2 - Renal Calculus (Pyeloscopy) with Laser Lithotripsy and Stent
A 52-year-old female with a 1.8 cm right lower pole renal calculus undergoes flexible ureteroscopy and pyeloscopy. The ureteroscope is advanced to the right renal pelvis and into the lower pole calyx. A Nitinol basket and ureteral access sheath are used. Holmium laser lithotripsy is performed using a combination fragmentation and basketing technique. Multiple fragments retrieved. A 6 Fr Γ 24 cm double-J stent is placed at conclusion of the procedure given the large stone burden and expected mucosal edema.
CPT: 52356--RT ICD-10-CM: N20.0 (calculus of kidney)
β Pyeloscopy (scope into renal pelvis/calyces) with lithotripsy and stent = 52356. The code descriptor covers ureteroscopy and/or pyeloscopy β both intrarenal and ureteral stones are captured under the same code family.
Example 3 - Bilateral Ureteroscopy: Lithotripsy + Stent Bilaterally
A 38-year-old male with bilateral ureteral stones β 8 mm right distal and 11 mm left mid-ureteral β undergoes bilateral ureteroscopy. Right ureter: Holmium laser lithotripsy performed, stone fragmented, right double-J stent placed. Left ureter: Holmium laser lithotripsy performed, stone fragmented, left double-J stent placed. Operative note explicitly documents each side separately with individual stone locations, lithotripsy parameters, and stent placements.
CPT:
- 52356--RT
- 52356--LT--51 (multiple procedures; -51 on lower-valued code, typically the second code listed β apply to the lesser-paying unit when Medicare processes)
ICD-10-CM: N20.1 (calculus of ureter β bilateral; no laterality modifier exists in ICD-10-CM stone codes)
β Both ureters treated with lithotripsy + stent = 52356 Γ 2, with laterality modifiers and -51. Bilateral surgery indicator is 3 (cannot be billed as one bilateral service) β two separate line items required with -LT/-RT and -51 on the lesser code. Verify payer NCCI policy β some payers bundle the second unit regardless.
Example 4 - Left Ureteroscopy: Lithotripsy + Stent AND Right Ureteroscopy: Lithotripsy Only (No Stent Right Side)
A 60-year-old female with bilateral stones β 1.4 cm left renal pelvis stone and 6 mm right distal ureteral stone β undergoes bilateral ureteroscopy. Left side: pyeloscopy, Holmium laser lithotripsy of the large left renal stone (dusting technique), left double-J stent placed given large stone burden. Right side: flexible ureteroscopy to right distal ureter, Holmium laser lithotripsy of small distal stone (complete fragmentation achieved), no stent placed on the right as stone was small, distal, and completely fragmented.
CPT:
- 52356--LT (lithotripsy + stent β left)
- 52353--RT--51 (lithotripsy only, no stent β right; 52353 is the correct code when no stent is placed)
ICD-10-CM: N20.2 (calculus of kidney with calculus of ureter β bilateral stone disease)
β Code selection must match what actually happened in each ureter. Left side = lithotripsy + stent = 52356--LT. Right side = lithotripsy only, no stent = 52353--RT. Do not default to 52356 for the right side simply because a stent was placed on the left. Each ureter is coded independently based on the intervention performed in that ureter.
Example 5 - Inpatient Admission: Urosepsis with Obstructing Ureteral Stone
A 67-year-old male with type 2 diabetes (E11.65) and CKD stage 3b (N18.32) is admitted with fever (39.8Β°C), chills, flank pain, leukocytosis (WBC 22,000), and hypotension. CT confirms a 1.3 cm obstructing left proximal ureteral stone with severe left hydronephrosis and hydroureter. Blood cultures drawn. IV antibiotics started. The attending physician documents βsepsis secondary to obstructing left ureteral calculus.β The urologist performs emergency left ureteroscopy with Holmium laser lithotripsy and double-J stent placement.
Principal Diagnosis: A41.9 (sepsis, unspecified organism β chiefly responsible for admission; the reason the patient required hospitalization was sepsis, not the stone per se) Secondary Diagnoses:
- N20.1 (calculus of ureter β source of obstruction)
- N13.2 (hydronephrosis with calculous obstruction)
- E11.65 (T2DM with hyperglycemia) β HCC 19
- N18.32 (CKD, stage 3b) β HCC 137
- R65.20 (Severe sepsis without septic shock β if criteria met and documented)
ICD-10-PCS Procedures:
- 0TF77ZZ (Fragmentation, left ureter, endoscopic)
- 0T778DZ (Dilation, left ureter with intraluminal device, endoscopic β stent; verify root operation per Coding Clinic)
MS-DRG: DRG 872 (Septicemia or Severe Sepsis w/o MV >96 hrs w/ MCC) or 873 (w/o MCC) depending on MCC status β N18.32 CKD 3b (CC), E11.65 DM with hyperglycemia (CC). If R65.20 (severe sepsis) is documented, this may itself serve as MCC, driving DRG 872. Confirm with current-year grouper.
β οΈ Critical Sequencing Decision: If the admitting reason had been documented differently β e.g., βobstructing ureteral stoneβ as the primary reason for admission with sepsis developing secondarily β the stone (N20.1 or N13.2) might be principal diagnosis (driving DRGs 693-695 in MDC 11). The distinction between these scenarios has significant reimbursement implications. A CDI or physician query clarifying the principal reason for admission is appropriate when documentation is ambiguous.
Example 6 - Inpatient Coding: Stent Exchange (Not 52356)
A 55-year-old female, 6 weeks post 52356 for left ureteral stone, returns to the OR for planned stent removal and exchange due to stent encrustation and persistent left flank discomfort. Cystoscopy performed; old left double-J stent removed; new left double-J stent placed over guide wire.
CPT: 52332--LT (cystoscopy with insertion of indwelling ureteral stent β stent exchange; the initial stone/lithotripsy has been resolved; this is a new, separate encounter for stent management) Note: If the old stent is removed AND a new stent placed, some coders also report the removal β verify payer guidance. 52310 (cystoscopy, simple, rigid) or 52315 may be reportable for the cystoscopy component of stent removal depending on documentation.
ICD-10-CM:
- T83.192A (mechanical complication of indwelling ureteral stent β encrustation, initial encounter)
- N20.1 (if residual stone disease still present) or Z96.0 (presence of genitourinary implant β the stent)
β This is not 52356 β no lithotripsy was performed. Stent exchange/removal alone is 52332 (insertion of new stent) and/or appropriate removal code. 52356 requires lithotripsy as a mandatory component. A stent exchange without lithotripsy is never 52356.
Example 7 - Procedure Partially Completed: Modifier -52 Scenario
A 48-year-old male undergoes right ureteroscopy for a 1.5 cm right proximal ureteral stone. The ureteroscope is advanced, the stone is identified, and laser lithotripsy is initiated. After partial fragmentation, the Holmium laser fiber fractures and cannot be replaced in the available timeframe. Partial fragmentation is documented. A double-J stent is placed over the guide wire to maintain drainage. The procedure is documented as βpartial ureteroscopic lithotripsy with stent placement β stone partially fragmented, procedure concluded due to equipment failure.β
CPT: 52356--RT--52 (reduced services β lithotripsy initiated but not fully completed; stent placed as planned) ICD-10-CM: N20.1, N13.2 (if hydronephrosis documented)
β -52 is appropriate when the intended procedure was 52356 but was not fully completed. The stent was placed as intended, and partial lithotripsy was performed, supporting 52356 over 52332 alone. The -52 modifier communicates to the payer that a reduced service was rendered and typically results in a proportional reduction in reimbursement (often 50%). Operative documentation must explicitly describe what was and was not completed and why.
Example 8 - Incorrectly Billed as 52353 + 52332 (Audit Scenario)
A urologist performs right ureteroscopy, Holmium laser lithotripsy of a right ureteral stone, and places a double-J stent at the conclusion. The claim is submitted as:
Submitted Codes: 52353 + 52332--59 β INCORRECT Correct Code: 52356--RT β Single code captures all three services
β This is the most frequently audited billing pattern for this code family. Reporting 52353 + 52332 instead of 52356 when both lithotripsy AND stent placement are performed in the same session:
- Violates the explicit CPT code descriptor β 52356 was specifically created to bundle lithotripsy with stent placement
- Violates NCCI bundling edits β 52332 is a Column II code to 52353 and cannot be unbundled with -59 in this context because there is a specific comprehensive code (52356) that already captures the combined service2
- May result in higher reimbursement than 52356 alone β making this pattern an active focus of payer audit programs, RAC audits, and OIG work plans
- Carries false claims risk if a pattern of systematic upcoding is identified
The correct billing practice: One code β 52356 β when lithotripsy and stent are both performed in the same ureteroscopic session.
π Related & Commonly Associated Codes
| Code | Description |
|---|---|
| 52351 | Diagnostic ureteroscopy and/or pyeloscopy (no therapeutic intervention) |
| 52352 | Ureteroscopy with removal or manipulation of calculus (no energy device) |
| 52353 | Ureteroscopy with lithotripsy (no stent placement) |
| 52354 | Ureteroscopy with biopsy and/or fulguration of lesion |
| 52355 | Ureteroscopy with resection of ureteral or pelvic tumor |
| 52332 | Cystoscopy with insertion of indwelling ureteral stent (stent only β no lithotripsy) |
| 52310 | Cystoscopy, simple (for stent removal β verify applicability) |
| 52315 | Cystoscopy, complicated (for difficult stent removal) |
| 50590 | Extracorporeal shock wave lithotripsy (ESWL) |
| 50080 | Percutaneous nephrostolithotomy (PCNL), stone up to 2 cm |
| 50081 | PCNL, stone greater than 2 cm |
| 50060 | Nephrolithotomy; removal of calculus by nephrotomy |
| 50130 | Pyelolithotomy; removal of calculus |
| 50392 | Introduction of ureteral catheter or stent into ureter, percutaneous approach |
| 50394 | Injection of contrast through nephrostomy tube for nephrography |
| 74420 | Urography, retrograde, with or without KUB |
| 74485 | Dilation of ureter, percutaneous |
| 76000 | Fluoroscopy, up to 1 hour |
| 88300 | Surgical pathology Level I (stone analysis β sent to pathology; billed by lab) |
| 82355 | Calculus; qualitative analysis (stone composition analysis) |
π Clinical & Documentation Tips for Coders
-
52356 is a single, complete code β the three components (ureteroscopy/pyeloscopy, lithotripsy, stent insertion) are inseparable when all three are performed in the same session in the same ureter. Never attempt to unbundle them. This is the most important compliance point for this entire code family.
-
Laterality modifiers (-LT/-RT) are essential for 52356 β always apply them. A claim submitted without laterality is a common denial trigger, especially for bilateral stone cases, and complicates audit trails if a patient has multiple procedures over time.
-
The operative note must explicitly document all three components to support 52356: (1) scope passage into the ureter/renal pelvis, (2) energy-based lithotripsy with the specific modality (Holmium laser, TFL, etc.) and technique (fragmentation, dusting, etc.), and (3) stent placement with stent size, length, and fluoroscopic confirmation of position. Missing documentation of any component creates coding vulnerability.
-
When stent is NOT placed, use 52353 for lithotripsy-only ureteroscopy β never default to 52356 just because stenting was considered. Operative report must confirm stent was or was not placed. The presence of βstent counselingβ or βplanned stent removal at follow-upβ in the post-op note is not the same as an intraoperative stent placement.
-
Stent removal is NOT part of the 52356 global package beyond the 000-day global period. Since the global period is zero days, any subsequent stent removal encounter (typically 1-6 weeks post-ureteroscopy) is fully separately billable as 52310, 52315, or the appropriate cystoscopy code with stent removal documentation.
-
ICD-10-PCS root operation for lithotripsy is Fragmentation (F), not Extirpation (C). This distinction is critical for accurate inpatient facility coding and DRG validation. Extirpation is used for basket extraction without energy fragmentation (52352 equivalent). When the primary mechanism is energy fragmentation (laser, ultrasonic), Fragmentation is the root operation even if some fragments are subsequently basketed.
-
CDI opportunity on inpatient stone cases: For inpatient 52356 cases, query the physician for: CKD staging (N18.xx β CC/MCC), sepsis vs. UTI vs. localized infection (A41.xx vs. N39.0 vs. N10), severity of hydronephrosis/obstruction, metabolic stone disease diagnosis (hyperparathyroidism, cystinuria, hyperoxaluria), and diabetes with complications. These comorbidities can elevate inpatient cases from DRG 695 (w/o CC/MCC) to DRG 694 or 693.
-
Stent string/external retention suture: If the surgeon leaves a stent string (retrieval string) externalized through the urethra for office-based stent removal without cystoscopy, document this explicitly. It does not change the CPT code but is important for follow-up visit coding (string pull removal is typically an office-based service β no separate procedure code required; billed as an E/M with N13.2 or stone aftercare code).
-
Pre-stenting as a staged procedure: If 52332 is performed at Session 1 (stent placement only, for passive ureteral dilation) and 52356 is performed at Session 2 (ureteroscopy, lithotripsy, new stent), both sessions are separately billable with their respective codes on separate dates of service. The 000-day global of 52332 means Session 2 is freely billable without modifier. This staged approach is common for large proximal ureteral or intrarenal stones where initial dilation improves subsequent ureteroscopic access.
-
Thulium fiber laser (TFL): An emerging alternative to Holmium:YAG for ureteroscopic lithotripsy; TFL procedures are still reported as 52356 (or 52353 without stent) β the energy modality does not change the CPT code. Document the specific laser type in the operative note for clinical completeness, but TFL vs. Holmium is not a CPT code differentiation point.
π References
Footnotes
-
CMS Physician Fee Schedule - MPFS Look-Up Tool. cms.gov/medicare/physician-fee-schedule β© β©2
-
CMS National Correct Coding Initiative (NCCI) Policy Manual for Medicare Services. cms.gov/medicare/coding-billing/national-correct-coding-initiative-edits β© β©2
-
AHA Coding Clinic for ICD-10-CM/PCS. American Hospital Association. ahacodingclinic.org β© β©2 β©3 β©4
-
CMS MS-DRG Definitions Manual & IPPS Final Rule. cms.gov/medicare/medicare-fee-for-service-payment/acuteinpatientpps β© β©2
Crystal's MCW Coder Hub